Seelos Therapeutics
SEEL
#10581
Rank
S$0.27 M
Marketcap
S$0.48
Share price
-31.49%
Change (1 day)
-98.21%
Change (1 year)

Earnings for Seelos Therapeutics (SEEL)

Earnings in 2024 (TTM): S$6.01 Million

According to Seelos Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -S$48.69 Million, an increase over its 2022 earnings that were of -S$94.68 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seelos Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$6.01 M-112.35%
2023 -S$48.69 Million-48.58%
2022 -S$94.68 Million14.07%
2021 -S$83 Million240.34%
2020 -S$24.39 Million-62.76%
2019 -S$65.49 Million587.73%
2018 -S$9.53 Million-36.54%
2017 -S$15.01 Million74.83%
2016 -S$8.59 Million-63.26%
2015 -S$23.36 Million-18.06%
2014 -S$28.51 Million46.19%
2013 -S$19.5 Million-31.67%
2012 -S$28.54 Million
2010 -S$26.74 Million448.63%
2009 -S$4.88 Million-25.83%
2008 -S$6.57 Million-45.65%
2007 -S$12.09 Million2.82%
2006 -S$11.76 Million-41.86%
2005 -S$20.22 Million-9.27%
2004 -S$22.29 Million114.92%
2003 -S$10.37 Million-70.78%
2002 -S$35.49 Million60.2%
2001 -S$22.16 Million70.3%
2000 -S$13.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.2 Billion-3,626.04%๐Ÿ‡บ๐Ÿ‡ธ USA